Immunosuppressant Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018–2026

1. Immunosuppressant Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018–2026 Immunosuppressant drugs are used to reduce or suppress the strength of body’s immune system. Immunosuppressant drugs are mostly used in organ transplantation procedures and also to treat some autoimmune diseases such as rheumatoid arthritis, psoriasis, multiple sclerosis, and others. Immunosuppressant drugs used in organ transplantation procedure are called as anti-rejection drugs. When an organ is transplanted, the person’s body identifies the transplanted organ as a foreign mass and the immune system will attack it, which, in turn, leads to organ rejection. In order to avoid such situations, immunosuppressant drugs are used to weaken the reaction against foreign organs. Regular blood tests are necessary to monitor the drug’s action on body. Immunosuppressant drugs are very powerful and might cause side effects such as kidney problems, high blood pressure, and liver disorders. Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/797 Effectiveness of immunosuppressant drugs as an anti-rejection compound in organ transplantation procedure to propel the market growth

2. Rising cases of organ failure and the requirement of organ transplantation are the major factors driving the growth of immunosuppressant drugs market. According to the data published by ONT- WHO Global Observatory On donation and Transplantation, in 2014, around 119,873 organs were transplanted globally and an increase of 1.8% was observed from 2013. Advancements in tissue engineering and transplantation procedures are fuelling the growth of immunosuppressant drugs market. The increase in rate of autoimmune diseases is also one of the important factors contributing to the growth of immunosuppressant drugs market. According to the American Autoimmune Related Disease Association (AARDA), in 2016, there were 50 million people suffering from autoimmune diseases in the United States. Immunosuppressant drugs have proven to be effective for the treatment of autoimmune diseases. Proven efficiency of kidney transplant for end-stage renal diseases to propel market demand The global immunosuppressant drugs market is segmented by application, drug type, dosage type, end users, and by region. On the basis of application, the global immunosuppressant drugs market is segmented into; •Autoimmune diseases •Organ transplant •Kidney transplant •Liver transplant •Heart transplant •Intestine transplant •Others On the basis of drug type, the global immunosuppressant drugs market is segmented into; •Calcineurin inhibitors •Antibodies •Corticosteroids •Antiproliferative agents •mTOR inhibitors •Others On the basis of dosage type, the global immunosuppressant drugs market is segmented into; •Tablets •Liquid •Injectable On the basis of end user, the global immunosuppressant drugs market is segmented into; •Hospitals

3. •Clinics •Transplant centers Request For Customization @ https://www.coherentmarketinsights.com/insight/request- customization/797 Key players focus on the approval and commercialization of their drugs Key industry players operating in the immunosuppressant drugs market include • Novartis AG, • Accord Healthcare, • AstellaPharma, • Watson Pharmaceuticals, • Genzyme Co., • Bristol-Myers Squibb, • Mylan Laboratories Inc., • GlaxoSmithKline Plc, • Roche. • About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com